-
Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: Exploring predictors of outcome as clues toward treatment improvement.
Reid MS, Jiang H, Fallon B, Sonne SC, Rinaldi P, Turrigiano E, Arfken CL, Robinson JA, Rotrosen J, Nunes EV. Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: Exploring predictors of outcome as clues toward treatment improvement. American Journal of Drug and Alcohol Abuse 2011;37(5):472-478.
-
Research partnerships between academic institutions and American Indian and Alaska Native Tribes and organizations: Effective strategies and lessons learned in a multisite CTN study.
Thomas LR, Rosa CL, Forcehimes AA, Donovan DM. Research partnerships between academic institutions and American Indian and Alaska Native Tribes and organizations: Effective strategies and lessons learned in a multisite CTN study. American Journal of Drug and Alcohol Abuse 2011;37(5):333-338.
-
Determining the primary endpoint for a stimulant abuse trial: Lessons learned from STRIDE (CTN 0037).
Trivedi MH, Greer TL, Potter JS, Grannemann BD, Nunes EV, Rethorst C, Warden D, Ring KM, Somoza EC. Determining the primary endpoint for a stimulant abuse trial: Lessons learned from STRIDE (CTN 0037). American Journal of Drug and Alcohol Abuse 2011;37(5):339-349.
-
NIDA’s Clinical Trials Network: An opportunity for HIV research in community substance abuse treatment programs.
Tross S, Campbell ANC, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes LF, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson CL, Holmes BW, Colfax GN, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM. NIDA’s Clinical Trials Network: An opportunity for HIV research in community substance abuse treatment programs. American Journal of Drug and Alcohol Abuse 2011;37(5):283-293.
-
Relation of study design to recruitment and retention in CTN trials.
Wakim PG, Rosa CL, Kothari P, Michel ME. Relation of study design to recruitment and retention in CTN trials. American Journal of Drug and Alcohol Abuse 2011;37(5):426-433.
-
Zero-inflated and hurdle models of count data with extra zeros: Examples from an HIV-Risk reduction intervention trial.
Hu M, Pavlicova M, Nunes EV. Zero-inflated and hurdle models of count data with extra zeros: Examples from an HIV-Risk reduction intervention trial. American Journal of Drug and Alcohol Abuse 2011;37(5):367-375.
-
Standardized patient walkthroughs in the National Drug Abuse Treatment Clinical Trials Network: Common challenges to protocol implementation.
Fussell HE, Kunkel LE, McCarty D, Lewy CS. Standardized patient walkthroughs in the National Drug Abuse Treatment Clinical Trials Network: Common challenges to protocol implementation. American Journal of Drug and Alcohol Abuse 2011;37(5):434-439.
-
Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A summary of findings.
Greenfield SF, Rosa CL, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson SJ, Gordon SM, Haynes LF, Killeen T, Miele GM, Tross S, Winhusen TJ. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A summary of findings. American Journal of Drug and Alcohol Abuse 2011;37(5):301-312.
-
Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: Meta-analytic findings across eight NIDA CTN trials.
Hartzler B, Donovan DM, Huang Z. Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: Meta-analytic findings across eight NIDA CTN trials. American Journal of Drug and Alcohol Abuse 2011;37(5):460-471.
-
Participant characteristics and buprenorphine dose.
Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W. Participant characteristics and buprenorphine dose. American Journal of Drug and Alcohol Abuse 2011;37(5):453-459.